AlphaSense

AlphaSense is a private market intelligence and search platform that uses artificial intelligence to index and analyze business and financial documents. Its content library combines company filings, broker research, news, financial data, and expert call transcripts, including material from its sister brand Tegus^[1].

The platform serves investment banks, hedge funds, private equity firms, asset managers, consultancies, and corporate teams across industries such as life sciences, energy, and technology. In June 2026 the company announced a $350 million funding round at a $7.5 billion valuation, reporting more than $600 million in annual recurring revenue^[2].

What It Does

AlphaSense applies search, summarization, and generative AI to a corpus the company describes as more than 500 million premium financial and business documents^[1]. Users run thematic and entity-level research, monitor earnings calls and filings, track competitive intelligence, and generate outputs with sentence-level citations. The platform includes an always-on AI agent called SuperAnalyst and a Deep Research capability for multi-step analysis^[1].

Content and Data

Content sources include global company filings, broker and aftermarket research, news, private and public financial data, customer-owned internal documents, and expert interview transcripts from Tegus^[1]. The company also publishes sentiment indices derived from adaptive AI scoring of earnings call language^[1].

Products and Delivery

Delivery is through the AlphaSense web platform, Microsoft PowerPoint and Excel add-ins, workflow connectors, and mobile apps^[1]. Expert call services let clients commission live consultations with subject matter experts alongside the transcript library^[1].

Buyers and Use Cases

The company states it is used by more than 7,000 enterprises, naming Pfizer, Microsoft, J.P. Morgan, McKesson, and PG&E among referenced customers^[1]. Documented use cases include competitive intelligence at Salesforce, strategy research at Dow, and due diligence workflows at Royalty Pharma^[1]. In alternative data terms, AlphaSense is primarily a text-mining and sentiment research layer over public and licensed documents rather than an exclusive dataset vendor.

History

AlphaSense raised a $150 million Series E led by BOND at a $2.5 billion valuation in 2021^[3]. In 2024 it announced a combination with expert-transcript provider Tegus, increasing its valuation to $4 billion alongside $650 million in new funding co-led by Viking Global Investors and BDT & MSD Partners with participation from J.P. Morgan Growth Equity Partners^[4]. The June 2026 round of $350 million valued the company at $7.5 billion and lifted total funding above $1 billion^[2].